Bioptik Technology Incorporation (4161)
Market Closed
2 Oct, 05:30 AM
TWSE 
XSAU Primary TWSE NT$
21. 65
-0.1
-0.4598%
NT$
- Market Cap
31.2 P/E Ratio
0.4% Div Yield
29,000 Volume
0.18 Eps
NT$ 21.75
Previous Close Want to track 4161 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bioptik Technology Incorporation (4161) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.35B
Trailing P/E (ttm) 11.64
Forward P/E -
PEG ratio 0.26
Price/Sales (ttm) 1.42
Price/Book (mrq) 1.26
Enterprise Value/Revenue 1.48
Enterprise Value/EBITDA 11.36
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 31.98K
Average volume (90 days) 25.35K
Price summary
52-Week low 21.2
52-Week high 29.35
Beta -
50-Day moving average 22.53
200-Day moving average 23.17
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.7
Trailing annual dividend yield 0.0323%
5-Year annual dividend yield -
Payout ratio 0.15
Dividend Date 14 Aug 2026
Ex-Dividend Date 16 Jul 2026
Last split factor 1,130.04:1,000
Last split Date 20 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.12%
Operating margin 0.08%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 15.89
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.88
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.7
Total debt (mrq) -
Total Debt/Equity (mrq) 0.47
Current ratio (mrq) 1.87%
Book value per share (mrq) 17.27
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
